Paradoxical Lymphadenopathy after Successful Treatment of Tuberculous Pleuritis
Journal Title: International Journal of Medical and Pharmaceutical Case Reports - Year 2016, Vol 6, Issue 5
Abstract
Tuberculous lymphadenopathy can paradoxically increase in size after initial clinical improvement. This paradoxical reaction during tuberculosis treatment is more common among HIV positive than non-HIV patients. However paradoxical reaction must not be primary diagnosis and it is crucial to be sure about patientsˋ good compliance in using antituberculosis medications as well as having sensitive mycobacterial strain. In addition other pathological problems (eg. neoplasia, other non tuberculous mycobacterial infections) should be excluded. We report a case of pleural tuberculosis, complicated by cervical lymphadenopathy near the end of her treatment.
Authors and Affiliations
Esfandiar Shojaei, Mehrnaz Rasoolinejad1, Saeed Kalantari
Keywords
Related Articles
- EP ID EP327725
- DOI 10.9734/IJMPCR/2016/24319
- Views 89
- Downloads 0
Acute Hypertension during Clonidine Taper in an Infant with Neonatal Abstinence Syndrome
A 2,600-gram infant treated with methadone and clonidine for Neonatal Abstinence Syndrome (NAS) developed acute hypertension following initiation of the clonidine taper, requiring treatment with a calcium channel blocker...
Unusual Cause of Rhabdomyolysis Causing Acute Renal Failure: Achillea millefolium and
Introduction: Rhabdomyolysis is a frequent disorder resulting from many different causes which may be apparent from the history, e.g. trauma, heavy exercise, intoxications. It contains both clinical and biochemical compo...
Hepatic Artery Mycotic Aneurysm and Microabscesses: A Rare Complication of Infective Endocarditis with Classical Quincke’s Symptom
Hepatic artery branch mycotic aneurysm causing intrahepatic biliary dilatation and associated with hepatic micro abscesses is a rare complication of infective endocarditis and patient presenting with classical Quincke’s...
Assessment of the Efficacy and Tolerance of Drepanoalpha® in the Management of Sickle Cell Disease in Kinshasa (DR Congo): About Ten Cases
Aims: The aim of this study is to assess the efficacy and safety of Drepanoalpha®, a nutraceutical used in the management of sickle cell disease in DR Congo. Study Design: Drepanoalpha® to ten sickle patients, evaluatio...
Myocardial Infarction in a Young Patient with Chronic Myeloid Leukemia after Nilotinib Use
Nilotinib is an analog of imatinib increasingly used for the treatment of imatinib-resistant chronic myeloid leukemia. It has been considered a well-tolerated drug with little side effects. The most common adverse effect...